Sanofi SA (NYSE:SNY)

39.96
Delayed Data
As of Apr 20
 -0.20 / -0.50%
Today’s Change
38.14
Today|||52-Week Range
50.65
-7.07%
Year-to-Date
Shire (SHPG) Turns Down Takeda's Third Buyout Proposition
Apr 20 / Zacks.com - Paid Partner Content
Top Analyst Reports for AbbVie, Berkshire & PepsiCo
Apr 17 / Zacks.com - Paid Partner Content
Sanofi to Divest European Generic Unit, Streamline Business
Apr 19 / Zacks.com - Paid Partner Content
Alexion (ALXN) to Acquire Wilson Therapeutics for $855M
Apr 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close40.16
Today’s open40.09
Day’s range39.91 - 40.14
Volume1,393,116
Average volume (3 months)1,692,214
Market cap$100.9B
Data as of 4:01pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-15.68%
Earnings growth (this year)+1.33%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+5.92%
P/E ratio21.8
Price/Sales2.73
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-0.41-0.44%
CELGCelgene-0.67-0.75%
BMYBristol-Myers Squibb-0.44-0.85%
GSKGlaxoSmithKline+0.12+0.30%
Data as of 4:02pm ET, 04/20/2018

Financials

Next reporting dateApril 27, 2018
EPS forecast (this quarter)$0.84
Annual revenue (last year)$39.5B
Annual profit (last year)$4.3B
Net profit margin10.81%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
Executive VP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts